
Conference Coverage
1 day ago
5 Things to Watch at SABCS 2026Latest Content

Shorts










Videos
All News

Copay cards, drugmaker assistance programs and charity foundations each help with cancer drug costs in different ways, and Medicare rules change which ones you can use. Here is how each works and where to start.

Long-term Kisqali data, a new targeted drug, blood tests and AI are among the topics to watch at the 2026 San Antonio Breast Cancer Symposium.

Dr. Elham Vosoughi, a breast medical oncologist at UCSF, discusses new breast cancer treatments, clinical trials and why genetic testing matters for families.

Through years of reflection, relationships and lessons from the ocean, I learned that accepting my scars was a gradual process.

Chemotherapy-free regimens for lymphoma and new drug combinations for myeloma are among the ASH 2026 studies patients should watch.

Births to cancer survivors in U.S. hospitals rose from 2016 to 2023, and most went to full term, but survivors had more serious delivery complications than people who never had cancer, a large study found.

Jessica Tovar, owner of Ink Esthetics, explained how paramedical tattooing can help restore the appearance of the areola and support patients after breast cancer surgery.

A registered nurse and breast cancer survivor, JoAnne Page became her husband Ray's care partner when his cancer stopped responding to treatment.

Told her metastatic breast cancer was terminal, a woman still alive four years later shares life as an In-Betweener and why society still hasn't caught up.

The FDA granted accelerated approval to Nelkarmi for adults with advanced ALK-positive non-small cell lung cancer that grew after prior ALK-targeted drugs.

From colon and rectal cancer to bladder and head and neck cancers, here are five FDA approvals from fall 2026 and what they mean for patients.

Answers to common questions about flu, COVID-19, RSV and other vaccines for people in cancer treatment, including which shots to avoid, the best timing around chemotherapy and what family members should do.

An expert from Case Western Reserve University explains how cancer cells survive treatment, why rare diseases are hard to study and why CAR-T therapy offers hope.

The FDA approved Wilserdly with everolimus for some ER-positive, HER2-negative, ESR1-mutated advanced breast cancers that grew after prior hormone therapy.

An updated ASTRO guideline released Oct. 27, 2026, says most men getting radiation for prostate cancer that has not spread can safely finish treatment in weeks instead of months, and many can finish in five sessions. Here is what that means for patients.




































